Anthropic's new flagship model Claude Opus 4.7 beat every benchmark we threw at it, and eats tokens like a hungry teenager.
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Claude Opus 4.7 is Anthropic's most intelligent model available to the general public. Notably, Anthropic said in a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results